Dendreon Corp (NASDAQ:DNDN)

During the Trading Day
1.50 +0.08 / +5.63%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.55 +0.05 / +3.33%
Volume: 368.5K
Health Technology

Company Description

Dendreon Corp. is a biotechnology company, which focuses on discovery, development and commercialization of novel therapeutics that improves cancer treatment options for patients. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.

Contact Information

Dendreon Corp.
1301 2nd Avenue
Seattle Washington 98101
P:(206) 256-4545
Investor Relations:
(206) 829-1522



Individual stakeholders5.44%
Mutual fund holders21.61%
Other institutional12.50%

Top Executives

W. Thomas AmickPresident, Chief Executive Officer & Director
Gregory R. CoxChief Financial Officer, Treasurer & VP
William MonteithExecutive Vice President-Technical Operations
Andrew S. SandlerChief Medical Officer & Executive Vice President
Robert L. CrottySecretary, Executive VP & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.